These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2993614)

  • 1. Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.
    Elliott RL; Marks N; Berg MJ; Portoghese PS
    J Med Chem; 1985 Sep; 28(9):1208-16. PubMed ID: 2993614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
    Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
    Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors.
    Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP
    Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides.
    Gafford JT; Skidgel RA; Erdös EG; Hersh LB
    Biochemistry; 1983 Jun; 22(13):3265-71. PubMed ID: 6349683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
    Mosberg HI; Hurst R; Hruby VJ; Gee K; Yamamura HI; Galligan JJ; Burks TF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5871-4. PubMed ID: 6310598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enkephalinase: selective inhibitors and partial characterization.
    Sullivan S; Akil H; Blacker D; Barchas JD
    Peptides; 1980; 1(1):31-5. PubMed ID: 6264406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
    Weinberger SB; Martinez JL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity.
    DiMaio J; Nguyen TM; Lemieux C; Schiller PW
    J Med Chem; 1982 Dec; 25(12):1432-8. PubMed ID: 6296388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
    Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
    Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
    Altstein M; Bachar E; Vogel Z; Blumberg S
    Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N-dialkylated leucine enkephalins as potential delta opioid receptor antagonists.
    Lovett JA; Portoghese PS
    J Med Chem; 1987 Jul; 30(7):1144-9. PubMed ID: 3037078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A photoaffinity reagent to label the opiate receptors of guinea pig ileum and mouse vas deferens.
    Fujioka T; Matsunaga T; Nakayama H; Kanaoka Y; Hayashi Y; Kangawa K; Matsuo H
    J Med Chem; 1984 Jul; 27(7):836-40. PubMed ID: 6330357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dipeptidyl carboxypeptidase and endopeptidase activities in the three enkephalin-hydrolysing metallopeptidases: "angiotensin-converting enzyme", thermolysin and "enkephalinase".
    Malfroy B; Schwartz JC
    Biochem Biophys Res Commun; 1985 Jul; 130(1):372-8. PubMed ID: 2992465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
    Edwards JV; Spatola AF; Lemieux C; Schiller PW
    Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
    Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
    J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between rat brain and mouse vas deferens delta opioid receptors.
    Vaughn LK; Wire WS; Davis P; Shimohigashi Y; Toth G; Knapp RJ; Hruby VJ; Burks TF; Yamamura HI
    Eur J Pharmacol; 1990 Feb; 177(1-2):99-101. PubMed ID: 2160370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
    Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
    Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of (D-Ala2,D-Leu5)enkephalinamide on isolated longitudinal muscle guinea pig and rat intestines.
    Venkova K; Radomirov R; Petkov VD
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):291-6. PubMed ID: 3613757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.